
NP-313
CAS No. 5397-78-4
NP-313( —— )
Catalog No. M34006 CAS No. 5397-78-4
NP-313 (NSC-4264) is a potent antithrombotic agent that inhibits platelet aggregation and activation by inhibiting thromboxane A 2 synthesis and selectively inhibiting SOCC-mediated Ca2+ efflux.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 73 | In Stock |
![]() ![]() |
5MG | 116 | In Stock |
![]() ![]() |
10MG | 187 | In Stock |
![]() ![]() |
25MG | 365 | In Stock |
![]() ![]() |
50MG | 542 | In Stock |
![]() ![]() |
100MG | 759 | In Stock |
![]() ![]() |
500MG | 1557 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameNP-313
-
NoteResearch use only, not for human use.
-
Brief DescriptionNP-313 (NSC-4264) is a potent antithrombotic agent that inhibits platelet aggregation and activation by inhibiting thromboxane A 2 synthesis and selectively inhibiting SOCC-mediated Ca2+ efflux.
-
DescriptionNP-313 is a potent antithrombotic agent that inhibits platelet aggregation and activation. NP-313 has dual inhibition of thromboxane A 2 synthesis and selective inhibition of SOCC-mediated Ca2+ inward flow.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetThrombin
-
RecptorThrombin | Calcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5397-78-4
-
Formula Weight249.65
-
Molecular FormulaC12H8ClNO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (100.14 mM; Ultrasonic )
-
SMILESO=C1C=2C(C(=O)C(Cl)=C1NC(C)=O)=CC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Heng-Lan Kuo, et al. NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry. Br J Pharmacol. 2011 Apr;162(8):1871-83.??
molnova catalog



related products
-
Argatroban
Argatroban is a direct, selective thrombin inhibitor.
-
Flovagatran
Flovagatran (TGN 255) is an orally active, potent, and selective inhibitor of thrombin and parenteral direct factor II.Flovagatran is used to study venous thromboembolism.
-
Dabigatran
A reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.